优先股及以公允价值计量的金融负债

港股IPO招股书披露先例 · 233 家公司,234 项

可转换可赎回优先股及附赎回权的金融工具,通常按公允价值计量并将变动计入损益,或确认为赎回负债,在往绩记录期间产生非现金公允价值亏损及相关利息。申请人一般于概要、风险因素及财务资料章节披露其计量方法、账面值及变动金额,说明相关变动属非现金性质,并解释该等负债将于上市时自动转换为普通股、重新分类至权益,或经赎回权终止及重组后终止确认。

2026-05-28Application Proof
麓鹏制药有限公司Lupeng Pharmaceutical Ltd.

优先股公平值变动重大且上市时将转换为股份

We recorded change in fair value of financial liabilities at FVTPL of RMB159.9 million and RMB73.9 million in 2024 and 2025, respectively, in line with fluctuations of the valuation of our preferred shares.

Financial Information · 第 229 页

Our preferred shares will be converted into Shares upon the [REDACTED], after which point we will no longer recognize any changes in fair value.

Financial Information · 第 229 页

Our preferred shares increased from RMB936.7 million as of December 31, 2024 to RMB1,730.1 million as of December 31, 2025.

Financial Information · 第 238 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-28Application Proof
苏州天瞳威视电子科技股份有限公司Suzhou Calmcar Electronics Technology Co., Limited

可赎回优先股公允价值变动致大额非现金亏损

For the years ended December 31, 2023, 2024 and 2025, we recorded loss on fair value changes of financial liabilities at FVTPL of RMB143.1 million, RMB458.4 million and RMB176.9 million, respectively.

Financial Information · 第 204 页

The loss on fair value changes of financial liabilities at FVTPL mainly represents equity value change of financial liabilities including preferred shares and convertible bonds, which were one-off, non-cash expenses not directly related to our operating performance.

Business · 第 155 页

The preferential rights were terminated on June 30, 2025.

Financial Information · 第 208 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-28Prospectus
天辰生物医药(苏州)股份有限公司LongBio Pharma (Suzhou) Co., Ltd.01779.HK

子公司可赎回股份产生的赎回负债

Our redemption liabilities on a subsidiary’s shares were RMB23.6 million and RMB0, respectively, as of December 31, 2024 and 2025.

Financial Information · 第 241 页

We entered into an agreement with Southeast Investment on March 28, 2025, to acquire the shares of LongBio Changshu held by Southeast Investment at the consideration of RMB23,990,000.

Financial Information · 第 241 页

LongBio Changshu was de-registered on May 29, 2025.

Financial Information · 第 241 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-28Application Proof
江苏零一汽车科技股份有限公司Jiangsu Zeron Automobile Technology Company Limited

附赎回权普通股账面值变动计入亏损

We define adjusted net loss (non-IFRS measure) as loss for the year adjusted by adding back (i) equity-settled share-based payment expenses, which are non-cash in nature, and (ii) changes in the carrying amount of ordinary shares with redemption rights, which are non-cash in nature.

Summary · 第 9 页

Such redemption liabilities will be reclassified to equity upon the [REDACTED].

Summary · 第 9 页

Changes in the carrying amount of ordinary shares with redemption rights | 12,100 | 20,515 | 41,824

Financial Information · 第 197 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-27Application Proof
科望医药集团Elpiscience Biopharmaceuticals, Inc.

可转换可赎回优先股公允价值亏损

For the years ended December 31, 2024 and 2025, we recorded fair value losses on convertible redeemable preferred shares of RMB39.6 million and RMB14.7 million.

Financial Information · 第 247 页

Upon [REDACTED], all the convertible redeemable preferred shares will automatically convert to ordinary shares and we do not expect to recognize any loss or gain on fair value changes of convertible redeemable preferred shares thereafter.

Financial Information · 第 247 页

We recorded convertible redeemable preferred shares as non-current liabilities of RMB3,241.1 million and RMB3,255.7 million as of December 31, 2024 and 2025, respectively.

Financial Information · 第 254 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-26Application Proof

可换股票据衍生负债公允值变动影响税率

Our effective rate increased from 20.3% for the nine months ended December 31, 2024 to 62.4% for the nine months ended December 31, 2025, mainly due to the influence of the fair value change of derivative liabilities amounting to USD118.2 million, which was related to the Convertible Notes, on our income before taxes.

Financial Information · 第 229 页

The conversion feature is classified as equity if the conversion results in a fixed amount of Shares being exchanged for a fixed amount of cash. Otherwise, the conversion feature is classified as a derivative liability.

Financial Information · 第 222 页

We define adjusted net income as net income adjusted by excluding certain non-cash items, items subject to volatility resulting from factors unrelated to our core operations in the corresponding period, and items that will settle in future periods, including impairment adjustments and reversal, foreign exchange gain or loss, dilution gain or loss, share-based compensation, share of gain or loss of associates, gain or loss on fair valuation of derivative liabilities, gain or loss on investments, and expenses that are unrelated to our normal operations and are not expected to continue.

Financial Information · 第 223 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-26Application Proof
福瑞泰克(浙江)智能科技股份有限公司Freetech (Zhejiang) Intelligent Technology Co., Ltd.

可赎回优先股赎回负债利息及终止

Interest expenses on redemption liabilities reduced to nil in 2025, primarily because the preferred rights associated with the preferred shares was terminated in 2024, and therefore the balance of the redemption liabilities was recorded as equity.

Financial Information · 第 239 页

(iii) reduced interest expenses on redemption liabilities associated with preferred shares, which was terminated in the first half of 2024.

Business · 第 181 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-21Application Proof
南京硅基智能科技集团股份有限公司Nanjing Silicon Intelligence Technology Group Co., Ltd.

可赎回投资赎回负债及增值于2024年终止

In November 2024, we entered into a supplemental agreement with the [REDACTED] Investors to unconditionally terminate our redemption obligations, pursuant to which, the redemption liabilities were reclassified as equity.

Business · 第 178 页

We recorded accretion of redemption liabilities of RMB58.7 million, RMB53.8 million and nil for the years ended December 31, 2023, 2024 and 2025, respectively, resulting from the interest expense thereof being included in accretion of redemption liabilities.

Financial Information · 第 212 页

We recorded redemption liabilities of RMB913.0 million, nil and nil as of December 31, 2023, 2024 and 2025, respectively.

Financial Information · 第 225 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-20Application Proof
踏歌智行科技股份有限公司Tage iDriver Technology Co., Ltd.

赎回负债高逾10亿元,2025年清零

As of December 31, 2023, 2024 and 2025 and March 31, 2026, our total redemption liabilities (including current and non-current portions) amounted to RMB977.8 million, RMB1,054.1 million, nil and nil, respectively.

Financial Information · 第 231 页

We recorded other losses of RMB26.3 million in 2024 and other gains of RMB19.8 million in 2025, primarily due to the gain on modification of redemption liabilities, which arose from the substantial modification gain in 2025 resulting from the further deferral of the redemption rights exercise date, and the decrease in the impairment losses recognized on property, plant and equipment (net), as we found several impairment indications such as project underperformance in 2024, which resulted in larger impairment losses compared with those in 2025.

Financial Information · 第 212 页

(2) Modification of redemption liabilities represents the gain arising from the remeasurement of redemption liabilities due to changes in their contractual terms.

Summary · 第 6 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-19Application Proof

可赎回优先股公允价值亏损扩大

We recorded fair value gains on convertible redeemable preferred shares of RMB19.6 million in 2023, and recorded fair value losses on convertible redeemable preferred shares of RMB43.3 million and RMB79.4 million in 2024 and 2025, respectively.

Financial Information · 第 223 页

As of December 31, 2023, 2024 and 2025, our convertible redeemable preferred shares were RMB1,876.1 million, RMB1,947.8 million and RMB1,818.7 million.

Financial Information · 第 234 页

The convertible redeemable preferred shares will be reclassified from liabilities to equity as a result of the conversion of convertible redeemable preferred shares into Ordinary Shares upon [REDACTED].

Financial Information · 第 234 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-19Application Proof
苏州东山精密制造股份有限公司Suzhou Dongshan Precision Manufacturing Co., Ltd.

Source Photonics优先股条款修订收益6.48亿元

Other gains/(losses), net of Source Photonics shifted from a loss of RMB50.2 million in 2023 to a gain of RMB634.8 million in 2024, primarily due to (i) an increase of RMB648.1 million in gain on modification of terms in Preferred Shares, (ii) a decrease of RMB49.1 million in fair value losses on financial liabilities at FVTPL, and (iii) an increase of RMB1.8 million in net foreign exchange gains, partially offset by a decrease of RMB10.3 million in net losses on disposal of property, plant and equipment and other long-term assets.

Financial Information · 第 232 页

The change was primarily due (i) a decrease of RMB648.1 million in gain on modification of terms in Preferred Shares, (ii) an increase of RMB41.6 million in compensation expense in connection with convertible bond and (iii) an increase of RMB58.0 million in fair value losses on financial liabilities at FVTPL, partially offset by a decrease of RMB1.9 million in net foreign exchange losses.

Financial Information · 第 229 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-14Prospectus
М੽Ԛ哦丹诺医药(苏州)股份有限公司TenNor Therapeutics (Suzhou) Limited06872.HK

Pre-IPO投资者赎回负债及金融成本

As of December 31, 2023, 2024 and 2025, we had redemption liabilities of RMB766.9 million, RMB931.5 million and nil, respectively.

Financial Information · 第 298 页

Pursuant to the supplemental agreement entered into between our Company and certain Pre-IPO Investors, the special rights related to recognition of the Company's the redemption liabilities ceased to be effective as of May 22, 2025.

Financial Information · 第 298 页

In 2023, 2024 and 2025, our finance costs amounted to RMB69.8 million, RMB68.2 million and RMB35.2 million, respectively.

Financial Information · 第 285 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-14Application Proof
安序源科技Axbio International Limited

优先股公平值变动亏损及上市时转换

Loss from changes in fair value of financial liabilities at FVTPL represents the fair value changes of the Series A-1 Preferred Shares and Series B Preferred Shares held by our Pre-[REDACTED] Investors, which is non-cash in nature. Upon completion of the [REDACTED], the Series A-1 Preferred Shares and Series B Preferred Shares will be converted into ordinary shares of our Company.

Financial Information · 第 226 页

Loss from changes in fair value of financial liabilities at FVTPL | 7,610 | 6,850

Financial Information · 第 227 页

mainly due to a decrease of US$0.8 million in loss from changes in fair value of financial liabilities at FVTPL, which is attributable to the the volatility in securities market.

Financial Information · 第 232 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-14Application Proof
广东合捷电器股份有限公司Guangdong Arcair Appliance Co., Ltd.

附赎回权股份确认为赎回负债,2025年赎回权终止

We recorded redemption liabilities of approximately RMB22.5 million and RMB24.1 million as of 31 December 2023 and 2024, respectively.

Financial Information · 第 249 页

In August 2025, pursuant to a supplementary agreement signed between our [REDACTED] Investor and us, the investors’ redemption rights have been irrecoverably terminated and shall be void ab initio.

Financial Information · 第 249 页

Hence, as of 31 December 2025 and 31 March 2026, our redemption liabilities on ordinary shares amounted to nil and nil, respectively.

Financial Information · 第 249 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-08Application Proof
江苏芯德半导体科技股份有限公司Jiangsu Silicon Integrity Semiconductor Technology Co., Ltd.

投资者赎回权相关负债利息影响业绩

It arises from redemption rights issued to [REDACTED] Investors, which will be terminated and re-designated to equity upon [REDACTED].

Summary · 第 5 页

Excluding this item eliminates the impact of [REDACTED] financing arrangements, thereby better reflecting our underlying operating performance.

Summary · 第 5 页

Interest on redemption liabilities(1) | 66,499 | 103,028 | 124,957

Summary · 第 4 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-08Application Proof
广东天农集团股份有限公司GUANGDONG TINOOS GROUP CO., LIMITED

投资者赎回权负债及公允价值变动亏损

In 2025, we recognized a loss of RMB4.6 million in respect of changes in the carrying amount of redemption liabilities.

Financial Information · 第 227 页

Such redemption liabilities arose from redemption rights granted to an investor in connection with the subscription of shares in 2025.

Financial Information · 第 227 页

Upon completion of our [REDACTED], the redemption right will be discharged and the carrying amount of the redemption liability will be reclassified to equity; and

Financial Information · 第 218 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-07Application Proof
深向科技股份有限公司DeepWay Technology Co., Ltd.

优先股公允价值变动影响损益

Gain (loss) on fair value change of financial liabilities at FVTPL primarily relates to preferred shares we issued in relation to certain Pre-[REDACTED] investments.

Financial Information · 第 215 页

We recorded gain on fair value change of financial liabilities at FVTPL of RMB44.8 million in 2023, as compared to loss on fair value change of financial liabilities at FVTPL of RMB56.3 million in 2024 and RMB56.9 million in 2025, respectively.

Financial Information · 第 215 页

We expect our net loss in 2026 to increase, primarily due to (i) fair value losses arising from the remeasurement of preferred shares, classified as financial liabilities at FVTPL prior to the [REDACTED] and (ii) share-based compensation expenses in relation to employee incentives previously granted, notwithstanding our continued efforts to improve operating performance.

Summary · 第 10 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-06Application Proof

赎回负债账面值变动每年影响损益

We recorded changes in the carrying amount of redemption liabilities of RMB175.0 million, RMB202.7 million and RMB219.0 million in 2023, 2024 and 2025, respectively.

Financial Information · 第 211 页

Our redemption liabilities consisted of (i) put option liabilities, and (ii) convertible redeemable preferred shares.

Financial Information · 第 225 页

Immediately following the completion of the Share Subdivision and the [REDACTED] (on the basis that all the Preferred Shares are converted into Ordinary Shares on a one-to-one basis and assuming that the [REDACTED] is not exercised)

Summary · 第 12 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-05Prospectus
剂泰科技(北京)股份有限公司Metis TechBio Co., Ltd.07666.HK

可赎回优先股赎回负债及可换股贷款公平值变动

We recorded redemption liabilities of RMB2,073.1 million, RMB2,250.2 million and nil as of December 31, 2023, 2024 and 2025, respectively.

Financial Information · 第 267 页

The increase in redemption liabilities as of December 31, 2024, compared to December 31, 2023, was primarily due to the accumulation of accrued interest as the redemption deadline approached.

Financial Information · 第 267 页

(1) Interest expenses on redemption liabilities are non-cash expenses arising from the redeemable preferred shares issued in connection with our historical equity investments.

Financial Information · 第 249 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看

Tell us